Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • AI Predicts Diseases, Advancing Toward HIV Cure, Acquisitions, New Partnerships

    Jun 29, 2023, 01:00 AM by User Not Found
    Bio-IT World | Illumina announces an AI algorithm that predicts disease-causing genetic mutations; American Gene Technologies’ new company will focus solely on advancing an HIV cure; Datacubed looks for genomic foundation for PTSD; and new partnerships for NTT Research, the National Cerebral and Cardiovascular Center, Seqera Labs, Genomics England, Complete Genomics. Plus, product updates from 10x Genomics, Thermo Fisher, Benchling, Saama Revvity, and more.
    Full story
  • Using An AI/ML Based Digital Platform To Build A More Robust And Capable Process

    Jun 28, 2023, 01:00 AM by User Not Found
    Bio-IT World | Legacy methods for developing a robust process and understanding process capability are limiting. Leveraging modern AI-based digital solutions throughout the product lifecycle provides expansive capability for creating more robust and capable processes.
    Full story
  • Pharma Targeting launches FMCG Targeting

    Jun 27, 2023, 14:14 PM by
    Pharma Targeting launches FMCG Targeting Exclusive offer for FMCG service providers increases requests for proposals and helps clients be first to market.
    Full story
  • Rhapsody Takes Top Spot for EMPI in Recent Black Book Ranking Over 900 Hospitals and Inpatient Organizations and 4,000 Physician Practices Participated in 2023 Financial and RCM Solution Survey

    Jun 27, 2023, 14:14 PM by
    Full story
  • DNAnexus Platform Enables Researchers to Access and Analyze Biomedical Data for Largest Health Research Program in Mexico

    Jun 27, 2023, 14:14 PM by
    DNAnexus today announced its platform is being used by researchers to access and analyze data from the Mexico City Prospective Study, the largest population health research study of its kind in Mexico.
    Full story
  • Cotiviti’s Quality Intelligence Earns NCQA Certified Measures Status for HEDIS® Measurement Year 2023

    Jun 27, 2023, 14:14 PM by
    Achievement marks 23rd consecutive year that Cotiviti’s quality measures have passed NCQA’s intensive validation process
    Full story
  • Revolutionizing Medical AI Development: Flywheel Announces $54 Million in Series D Funding led by Novalis LifeSciences and NVentures

    Jun 27, 2023, 14:13 PM by
    Flywheel, the leading medical imaging data and AI platform, announces it has raised $54 million in Series D funding.
    Full story
  • Light Chain Bioscience Chooses Genedata to Digitalize Cell Line & Bioprocess Development

    Jun 27, 2023, 14:13 PM by
    Off-the-shelf workflow platform accelerates development of manufacturing processes for innovative biotherapeutics
    Full story
  • NCC Group Appoints New Chief Operating Officer, Kevin Brown

    Jun 27, 2023, 14:09 PM by
    NCC Group, one of the world’s largest security consultancies with over 35 global offices, 2,000 employees and 14,000 clients, has appointed Kevin Brown as Chief Operating Officer.
    Full story
  • OMAPiX Announces Strategic Partnerships with Leading Spatial Biology Platform Providers to Accelerate Life Science Research and Drug Development

    Jun 27, 2023, 14:09 PM by
    OMAPiX announces strategic collaborations with Vizgen, Resolve Biosciences, and Ultivue as part of its ongoing commitment to expand its services portfolio in Europe and North America.
    Full story
  • Persist AI Adopts Scispot to operate as a Digital Biotech company

    Jun 27, 2023, 14:08 PM by
    Persist AI leverages Scispot's advanced tech stack to automate research workflows and scale AI capabilities, accelerating drug formulation development
    Full story
  • Follow the Money: AI Drug Treatments, Stocks, Quantum Metabolic Polarizers, More

    Jun 27, 2023, 01:00 AM by User Not Found
    Bio-IT World | Leveraging AI for drug treatments, stock investments, revolutionizing metabolic MRIs with polarizers, and more.
    Full story
  • Search Is On For Brain Markers Of Suicide Risk

    Jun 23, 2023, 01:00 AM by User Not Found
    Bio-IT World | Scientists and clinicians have been looking for behavioral predictors of suicide for decades now, and yet the most reliable detection method remains self-disclosure by individuals who feel life is not worth living. The work of trying to understand the brain mechanisms behind suicide is a newer, “burgeoning bubble” of research to better foresee who is in peril of taking their own life.
    Full story
  • Temple Health Embeds AI-Powered Medication Management Solution in its Epic EHR

    Jun 22, 2023, 10:16 AM by
    Temple Health Embeds AI-Powered Medication Management Solution in its Epic EHR - Medication History and Prescription Price Transparency Solutions from DrFirst Fill Data Gaps, Prevent Errors, and Support Patient Adherence to Medication Therapy
    Full story
  • Molecule Takes On Deadly Cancer By Inhibiting ‘Unfolded Protein Response’

    Jun 22, 2023, 01:00 AM by User Not Found
    Bio-IT World | Researchers in a joint European network report on a specially developed molecule known as Z4P that could deliver fresh hope to patients with glioblastoma, the most aggressive malignant primary brain tumor with a less than 7% survival rate five years post-diagnosis. As an adjunct to gold-standard chemotherapy, Z4P effectively inhibits the stress management pathway of cancer cells so they self-destruct.
    Full story
  • CD Formulation Expands Its Healthcare Product Development and OEM/ODM Services

    Jun 21, 2023, 10:34 AM by
    Full story
  • Cresset Creates New Vice President Role to Lead their Discovery CRO Business

    Jun 21, 2023, 10:34 AM by
    Nick Foster appointed Vice President of Cresset Discovery CRO business
    Full story
  • Platform and Projects: Genomics England’s New Efforts

    Jun 21, 2023, 01:00 AM by User Not Found
    Bio-IT World | At the Bio-IT World Conference & Expo last month, members of the Genomics England team shared about the organization’s history, vision, and what it’s working on now.
    Full story
  • CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023

    Jun 20, 2023, 10:56 AM by
    CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023 CluePoints and partners present and discuss the results of a new study examining RBQM use and adoption.
    Full story
  • Alfa Chemistry Commenced Offering Nonlinear Crystals and Precision Optical Materials

    Jun 20, 2023, 10:56 AM by
    Full story
  • «
  • 71
  • 72
  • 73
  • 74
  • 75 (current)
  • 76
  • 77
  • 78
  • 79
  • 80
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy